Tissue-engineered small intestine improves recovery after massive small bowel resection

Annals of Surgery

Volumn 240, Issue 5, 2004, Pages 748-754

  Grikscheit, Tracy C ^a,b   Siddique, Aleem ^a,b   Ochoa, Erin R ^a,b   Srinivasan, Ashok ^a   Alsberg, Eben ^c   Hodin, Richard A ^a,b   Vacanti, Joseph P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Center for Integration of Medicine and Innovative Technology   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA ACTIN; DNA; GREEN FLUORESCENT PROTEIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; PROTEIN S 100; RNA; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG; VILLIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; LAPAROTOMY; MALE; MOLONEY LEUKEMIA ONCOVIRUS; MORPHOMETRICS; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SHORT BOWEL SYNDROME; SIDE TO SIDE ANASTOMOSIS; SMALL INTESTINE RESECTION; TISSUE ENGINEERING; VARICELLA ZOSTER VIRUS; VESICULAR STOMATITIS VIRUS; WEIGHT GAIN; WEIGHT REDUCTION;

ACTINS; ALKALINE PHOSPHATASE; ANIMALS; BODY WEIGHT; GASTRINS; GASTROINTESTINAL TRANSIT; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; MALE; MICROFILAMENT PROTEINS; ORGANOIDS; RATS; RATS, INBRED LEW; RNA; S100 PROTEINS; TISSUE ENGINEERING; VITAMIN B 12;

EID: 7044274593     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000143246.07277.73     Document Type: Article

References (21)

1. Byrne TA, Nompleggi DJ, Wilmore DW. Advances in the management of patients with intestinal failure. Trans Proc. 1996;28:2683-2690.
2. Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol. 2002;34:207-220.
3. Stollman NH, Neustater BR, Rogers AI. Short bowel syndrome. Gastroenterologist. 1996;4:118-128.
4. Thompson JS. Management of the short bowel syndrome. Gastroenterol Clin North Am. 1994;23:403-420.
5. Lykins TC. Comprehensive modified diet simplifies nutrition management. J Am Diet Assoc. 1998;98:309-315.
6. Choi RS, Vacanti JP. Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Trans Proc. 1997;848-851.
7. Evans GS, Flint N, Somers AS, et al. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci. 1992;101:219.
8. Grikscheit T, Ochoa ER, Ramsanahie A, et al. Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg. 2003;238:35-41.
9. Grikscheit T, Ochoa ER, Srinivasan A, et al. Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg. 2003;126:537-544.
10. Grikscheit T, Srinivasan A, Vacanti JP. Tissue-engineered stomach: a preliminary report of a versatile in vivo model with therapeutic potential. J Pediatr Surg. 2003;38:1305-1309.
11. Grikscheit TC, Ogilvie JB, Ochoa ER, et al. Tissue engineered colon functions in vivo. Surgery. 2002;132:200-204.
12. Choi RS, Pothoulakis C, Kim BS, et al. Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine. J Pediatr Surg. 1998;33:991-997.
13. Perez A, Grikscheit TC, Blumberg RS, et al. Tissue-engineered small intestine: ontogeny of the immune system. Transplantation. 2002;74:619-623.
14. Ramsanahie A, Duxbury M, Grikscheit T, et al. The effect Of GLP-2 on mucosal morphology and SGLT1 expression in tissue engineered neointestine. Am J Physiol Gastrointest Liver Physiol. In press.
15. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA. 1996;93:11400-11406.
16. Henthorn PS, Raducha M, Edwards YH, et al. Nucleotide and amino acid sequences of human intestinal alkaline phosphatase: close homology to placental alkaline phosphatase. Proc Natl Acad Sci USA. 1987;84:1234-1238.
17. Arpin M, Pringault E, Finidori J, et al. Sequence of human villin: a large duplicated domain homologous with other actin-severing proteins and a unique small carboxy-terminal domain related to villin specificity. J Cell Biol. 1993;268:11426-11434.
18. Cleveland DW, Lopata MA, MacDonald RJ, et al. Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell. 1980;20:95-105.
19. Nightingale JM, Kamm MA, van der Sijp JR, et al. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut. 1996;39:267-272.
20. Moog F. Developmental adaptations of alkaline phosphatases in the small intestine. Fed Proc. 1962;21:51-56.
21. Robine S, Sahuquillo-Merino C, Louvard D, et al. Regulatory sequences on the human villin gene trigger the expression of a reporter gene in a differentiating HT-29 intestinal cell line. J Biol Chem. 1993;268:11426-11434.